Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Lingying Wu"'
Autor:
Chao Zhang, Qiang Guo, Lifeng Chen, Zheming Wu, Xiao-Jian Yan, Chengyang Zou, Qiuxue Zhang, Jiahong Tan, Tian Fang, Qunxian Rao, Yang Li, Shizhen Shen, Min Deng, Liewei Wang, Huanyao Gao, Jia Yu, Hu Li, Cheng Zhang, Somaira Nowsheen, Jake Kloeber, Fei Zhao, Ping Yin, Chunbo Teng, Zhongqiu Lin, Kun Song, Shuzhong Yao, Liangqing Yao, Lingying Wu, Yong Zhang, Xiaodong Cheng, Qinglei Gao, Jian Yuan, Zhenkun Lou, Jin-San Zhang
Publikováno v:
Signal Transduction and Targeted Therapy. 8
Poly (ADP-ribose) polymerase (PARP) inhibitors are one of the most exciting classes of targeted therapy agents for cancers with homologous recombination (HR) deficiency. However, many patients without apparent HR defects also respond well to PARP inh
Autor:
Jia Zeng, Ning Li, Lin Xiu, Tiantian Wang, Lingying Wu, Jian Li, Jing Liu, Ting-Ting Liu, Hong-Qing Cai, Jing Yu, Lei-Lei Liang
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-14 (2021)
Cancer Cell International
Cancer Cell International
Background Ovarian cancer (OC) is the most lethal gynaecological tumor. Changes in glycolysis have been proven to play an important role in OC progression. We aimed to identify a novel glycolysis-related gene signature to better predict the prognosis
Publikováno v:
Journal of Experimental & Clinical Cancer Research. 41
Background Metastasis is the main cause of mortality in cervical cancer (CC). Circular RNAs (circRNAs) have been demonstrated to play a crucial role in carcinoma biology. However, the expression and function of circRNAs in cervical cancer metastasis
Background CircN4BP2L2 was previously identified to be significantly decreased in epithelial ovarian cancer (EOC) and was associated with disease progression. The aim of this study was to evaluate the diagnostic value of plasma circN4BP2L2 using the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a0d2745d931b37874bf4a718cdd5bd
https://doi.org/10.21203/rs.3.rs-1544047/v1
https://doi.org/10.21203/rs.3.rs-1544047/v1
Autor:
Jusheng An, Jie Tang, Benjamin X. Li, Huihua Xiong, Hui Qiu, Lin Luo, Li Wang, Danbo Wang, Qi Zhou, Qin Xu, Honglin Song, Yunyan Zhang, Hongping Zhang, Yujie Li, Xiaohui Yu, Jing Zhang, Rachel Ng, Wayne Zhao, Michael Wong, Xiangrong Dai, Guiling Li, Lingying Wu
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 28(23)
Purpose: This study (ClinicalTrials.gov identifier, NCT03676959) is an open, phase I dose-escalation and expansion study investigating the safety and efficacy of the recombinant, fully human anti–programmed death ligand 1 (PD-L1) mAb socazolimab in
Autor:
Ning Li, Youzhong Zhang, Jing Wang, Jianqing Zhu, Li Wang, Xiaohua Wu, Desheng Yao, Qiang Wu, Jihong Liu, Junying Tang, Rutie Yin, Ge Lou, Ruifang An, Guonan Zhang, Xiaoping Xia, Qingshui Li, Yaping Zhu, Hong Zheng, Xinfeng Yang, Yuanjing Hu, Xin Zhang, Min Hao, Yi Huang, Zhongqiu Lin, Dong Wang, Xiaoqing Guo, Shuzhong Yao, Xiaoyun Wan, Huaijun Zhou, Liangqing Yao, Xielan Yang, Heng Cui, Yuanguang Meng, Songling Zhang, Jing Qu, Ben Zhang, Jianjun Zou, Lingying Wu
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(22)
PURPOSE This phase III trial aimed to explore the efficacy and safety of fuzuloparib (formerly fluzoparib) versus placebo as a maintenance treatment after response to second- or later-line platinum-based chemotherapy in patients with high-grade, plat
Autor:
Leilei Liang, Jian Li, Jing Yu, Jing Liu, Lin Xiu, Jia Zeng, Tiantian Wang, Ning Li, Lingying Wu
Publikováno v:
Cancer Cell International. 22
Background Ovarian cancer (OC) is an invasive gynaecologic cancer with a high cancer-related death rate. The purpose of this study was to establish an invasion-related multigene signature to predict the prognostic risk of OC. Methods We extracted 97
Publikováno v:
BMC Cancer
BMC Cancer, Vol 22, Iss 1, Pp 1-15 (2022)
BMC Cancer, Vol 22, Iss 1, Pp 1-15 (2022)
Background Circular RNAs (circRNAs) are more stable than linear RNA molecules, which makes them promising diagnostic biomarkers for diseases. By circRNA-sequencing analysis, we previously found that circN4BP2L2 was significantly decreased in epitheli
Autor:
Tiantian, Wang, Jie, Tang, Hongying, Yang, Rutie, Yin, Jingru, Zhang, Qi, Zhou, Ziling, Liu, Lanqin, Cao, Li, Li, Yi, Huang, Kui, Jiang, Wei, Wang, Fenglin, She, Ni, Guan, Zhiguo, Hou, Ning, Li, Lingying, Wu
Publikováno v:
JAMA Oncology. 8:1169
There are substantial unmet therapeutic needs in patients with platinum-resistant recurrent ovarian cancer (PROC), and novel therapeutic strategies should be explored.To evaluate the efficacy and safety of treatment with apatinib (a vascular endothel
Publikováno v:
Cancers; Volume 14; Issue 15; Pages: 3655
Background: The prognosis of older patients with ovarian cancer is poor. We evaluated the effect of chronological age and different treatment characteristics on the prognosis of older patients with ovarian cancer; Methods: The study retrospectively a